KAIZEN

UEM Edgenta Elevates Middle East Presence Through A Strategic Partnership

Retrieved on: 
Saturday, December 9, 2023
Climate change, Carbon footprint, Customer, Property technology, Conference, Partnership, Kaizen, UEM, Khazanah Nasional, Software as a service, International, Investment advisory, Environment, Digital transformation, Health, Happiness, UNFCCC, YB, UEM Edgenta, UEM Group, WELL, Software, Natural Resources, KAIZEN, Management

UEM Edgenta Berhad proudly announces a strategic partnership with KAIZEN Group. This collaboration seeks to create an integrated real estate services platform, harnessing UEM Edgenta's smart buildings and sustainability solutions to meet the escalating sustainability demands in Dubai and the broader Middle East market.

Key Points: 
  • The immediate synergy between UEM Edgenta and KAIZEN Group's property management and facility management capabilities is fast-tracking UEM Edgenta's vision to curate an integrated real estate services platform.
  • Our strategic partnership is poised to redefine customer satisfaction by seamlessly integrating wellness, health, and happiness into every facet of our services.
  • UEM Edgenta Group is excited about the myriad of new opportunities and synergies this partnership brings, solidifying its position as a key player in delivering innovative and sustainable real estate solutions in Dubai and the broader Middle East.
  • For further information on UEM Edgenta's presence in the Middle East and its other initiatives, logon to https://www.uemedgenta.com .

UEM Edgenta Elevates Middle East Presence Through A Strategic Partnership

Retrieved on: 
Monday, December 4, 2023
Customer, KAIZEN, Software, Carbon footprint, Property technology, International, Third-party logistics, Investment advisory, Kaizen, WELL, Health, World Communication Awards, Conference, Partnership, UNFCCC, Software as a service, Happiness, Digital transformation, Sales, Management, Online shopping, UEM Edgenta

DUBAI, United Arab Emirates, Dec. 4, 2023 /PRNewswire/ -- UEM Edgenta Berhad ("UEM Edgenta" or the "Company"), a leading provider of Asset Management and Infrastructure Solutions across the region, proudly announces its strategic partnership of a 60% stake in KAIZEN Group at the Conference of the Parties of the UNFCCC ("COP28") in Dubai. KAIZEN Group is a tech-enabled property management services company headquartered in the UAE. 

Key Points: 
  • Our strategic partnership is poised to redefine customer satisfaction by seamlessly integrating wellness, health, and happiness into every facet of our services.
  • UEM Edgenta Group is excited about the myriad of new opportunities and synergies this partnership brings, solidifying its position as a key player in delivering innovative and sustainable real estate solutions in Dubai and the broader Middle East.
  • Present together with Managing Director/Chief Executive Officer of UEM Edgenta, at the exchange of documents ceremony was Fadi Marwan Alnwilati Almasri, the Chief Executive Officer of KAIZEN Group.
  • For further information on UEM Edgenta's presence in the Middle East and its other initiatives, logon to https://www.uemedgenta.com .

Cardiovascular Systems, Inc. Enrolls First Patient in Japan for Kaizen Clinical Study

Retrieved on: 
Wednesday, January 11, 2023
Medical Devices, Other Health, Health, Clinical Trials, Cardiology, De novo, OAS, Trial of the century, Interventional cardiology, Diamondback, Safety, Coronary artery disease, Stent, Plaque, Patient, Artery, Atherosclerosis, CSI, Popliteal artery, KAIZEN, PAD, Physician, Peripheral artery disease, Pharmaceutical industry, Medical device, Medical imaging

The first KAIZEN patient was enrolled by Tatsuya Nakama, M.D., Vice Director, Department of Cardiology, Tokyo Bay Urayasu Ichikawa Medical Center.

Key Points: 
  • The first KAIZEN patient was enrolled by Tatsuya Nakama, M.D., Vice Director, Department of Cardiology, Tokyo Bay Urayasu Ichikawa Medical Center.
  • Dr. Nakama said, “I felt that the Diamondback 360© Peripheral OAS offered both effective treatment and ease of use.
  • OAS has demonstrated safety and efficacy in the U.S. population and this study is designed to confirm this in Japan.
  • I believe the Diamondback 360© Peripheral OAS has great potential for this underserved patient population, and I look forward to evaluating it in Japan.